Treatment of bipolar depression

descriptionPublicationkeyboard_double_arrow_right Article 01 Mar 1995 English Publisher:American Psychiatric Association PublishingJournal:Psychiatric Services, volume 46, pages 229-230 (issn: 1075-2730, eissn: 1557-9700,

Copyright policy )

Authors: A, Dantzler; C, Salzman;

doi: 10.1176/ps.46.3.229

pmid: 7796207

Treatment of bipolar depression

- Summary
- Subjects
- Metrics

Abstract

(MAOIs) may be especially effective in the treatment of bipolar depression that is refractory to tricyclic antidepressants, especially depression with anergic features (7). There are no studies comparing the efficacy of MAOIs and selective serotonin reuptake inhibitors (SSRIs) in the treatment ofbipolar depression. Limited published studies have suggested that SSRIs appear to be as effective and possibly more effective than older agents in treating bipolar depression (6,8). Bupropion is also

Related Organizations

Massachusetts Mental Health Center
United States

Keywords

Bipolar Disorder, Carbamazepine, Monoamine Oxidase Inhibitors, Humans, Drug Therapy, Combination, Lithium, Antidepressive Agents

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	7
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average